Data as of Mar 07
| +0.08 / +1.45%|
The 1 analysts offering 12-month price forecasts for Nymox Pharmaceutical Corp have a median target of 9.50, with a high estimate of 9.50 and a low estimate of 9.50. The median estimate represents a +69.64% increase from the last price of 5.60.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.